Potent anti-leukemic activity of a specific cyclin-dependent kinase 9 inhibitor in mouse models of chronic lymphocytic leukemia

類似資料

• Anti-leukemic effect of CDK9 inhibition in T-cell prolymphocytic leukemia
  著者:: Johansson, Patricia, 等
  出版事項: (2020)
• CpG stimulation of chronic lymphocytic leukemia cells induces a polarized cell shape and promotes migration in vitro and in vivo
  著者:: Dampmann, Maria, 等
  出版事項: (2020)
• Identification of Atuveciclib (BAY 1143572), the First Highly Selective, Clinical PTEFb/CDK9 Inhibitor for the Treatment of Cancer
  著者:: Lücking, Ulrich, 等
  出版事項: (2017)
• Cyclin-Dependent Kinase 7 Controls mRNA Synthesis by Affecting Stability of Preinitiation Complexes, Leading to Altered Gene Expression, Cell Cycle Progression, and Survival of Tumor Cells
  著者:: Kelso, Timothy W. R., 等
  出版事項: (2014)
• A Novel CDK7 Inhibitor of the Pyrazolotriazine Class Exerts Broad-Spectrum Antiviral Activity at Nanomolar Concentrations
  著者:: Hutterer, Corina, 等
  出版事項: (2015)